Clinical neurochemistry is a branch of neuroscience that focuses on the chemical processes and neurotransmitter systems within the nervous system, particularly as they relate to neurological and psychiatric disorders. Neurotransmitters are chemical messengers that transmit signals between neurons in the brain and play a critical role in regulating various physiological and psychological functions, including mood, cognition, behavior, and emotion. Clinical neurochemists study the synthesis, release, reuptake, and metabolism of neurotransmitters such as serotonin, dopamine, norepinephrine, glutamate, and gamma-aminobutyric acid (GABA). They also investigate how alterations in neurotransmitter systems contribute to the pathophysiology of neurological and psychiatric disorders, such as depression, anxiety, schizophrenia, bipolar disorder, Parkinson's disease, Alzheimer's disease, and substance use disorders. Clinical neurochemists use a variety of research methods and techniques, including biochemical assays, neuroimaging (e.g., PET, SPECT), pharmacological studies, and genetic analyses, to elucidate the neurochemical basis of these disorders. By understanding the neurochemical mechanisms underlying brain function and dysfunction, clinical neurochemists aim to develop new pharmacological treatments and interventions to alleviate symptoms, improve quality of life, and promote brain health.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom